Updated Jul 16, 2026
HUNT DOUGLAS M has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $98K.

| Role | See Remarks |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | PBYI | PUMA BIOTECHNOLOGY, INC. | S — Open-market sale | 8.5K | $8.26 | $70K |
| 2026-02-21 | PBYI | PUMA BIOTECHNOLOGY, INC. | A — Grant or award | 49.4K | $0.00 | |
| 2025-07-08 | PBYI | PUMA BIOTECHNOLOGY, INC. | S — Open-market sale | 3.4K | $3.54 | $12K |
| 2025-07-08 | PBYI | PUMA BIOTECHNOLOGY, INC. | S — Open-market sale | 4.4K | $3.53 | $15K |
HUNT DOUGLAS M is a corporate insider — currently tracked as See Remarks of PUMA BIOTECHNOLOGY, INC. (PBYI). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($98K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live HUNT DOUGLAS M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.